Haemonetics to Host Investor Day Event on June 29, 2022

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) will host an Investor Day on June 29, 2022, at 10:00 AM EDT in Boston. The event aims to share insights on the Company’s long-term strategic plans, key initiatives, and financial outlook. It will be hybrid, allowing in-person attendance and a simultaneous webcast for remote participants. Registration is required via the Company's Investor Relations website. A replay and presentation materials will be available post-event on Haemonetics' website.

BOSTON, May 10, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that it will host an Investor Day in Boston on Wednesday, June 29, 2022 beginning at 10:00 AM EDT. Members of Haemonetics' leadership team will share presentations and hold a question-and-answer session on the Company's long-term strategic planning, key business initiatives and financial outlook.

Haemonetics' Investor Day will be a hybrid event, with in-person attendance available to members of the capital markets community, and a simultaneous webcast available for the media, individual investors and other interested parties who wish to join virtually. All attendees must register for the event on the Company's Investor Relations website at https://irday.haemonetics.com.

A replay of the event will be available on the Investor Relations section of Haemonetics' website (www.haemonetics.com) after the event. Corresponding presentation materials will also be available for download at the Company's website following the event.

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury	David Trenk, Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olgaguyette@haemoneticscom	davidtrenk@haemoneticscom
Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776
josh.gitelson@haemoneticscom

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-host-investor-day-event-on-june-29-2022-301543451.html

SOURCE Haemonetics Corporation

FAQ

What is the date and time for Haemonetics' Investor Day?

Haemonetics' Investor Day is scheduled for June 29, 2022, at 10:00 AM EDT.

Where will Haemonetics' Investor Day be held?

The event will take place in Boston.

Is there an online option to attend Haemonetics' Investor Day?

Yes, there will be a simultaneous webcast available for those who wish to attend remotely.

How can I register for Haemonetics' Investor Day?

Registration for the event can be done on Haemonetics' Investor Relations website.

Will there be a replay of Haemonetics' Investor Day?

Yes, a replay of the event will be available on Haemonetics' website after the event concludes.

What will be discussed at Haemonetics' Investor Day?

The leadership team will present the Company’s long-term strategic planning, key business initiatives, and financial outlook.